Brief: Quoin Pharmaceuticals Announces Further International Expansion Of Ongoing Clinical Trials For Netherton Syndrome
22/10/2024 13:14
Oct 22 (Reuters) - Quoin Pharmaceuticals Ltd 2EBy.BE :
* QUOIN PHARMACEUTICALS ANNOUNCES FURTHER INTERNATIONAL
EXPANSION
OF ONGOING CLINICAL TRIALS FOR NETHERTON SYNDROME
* QUOIN PHARMACEUTICALS LTD - EXPANDS NETHERTON SYNDROME
STUDIES
TO UK
* QUOIN PHARMACEUTICALS LTD - PREPARING TO OPEN ADDITIONAL
SITES
IN WESTERN AND EASTERN EUROPE
Source text for Eikon: ID:nGNXbcdlY6
Further company coverage: 2EBy.BE
((Reuters.Briefs@thomsonreuters.com))
Recent news on Quoin Pharmaceuticals
See all newsQuoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM